您的位置: 专家智库 > >

国家重点基础研究发展计划(2006CB504202)

作品数:1 被引量:0H指数:0
发文基金:国家重点基础研究发展计划更多>>
相关领域:农业科学自然科学总论更多>>

文献类型

  • 1篇中文期刊文章

领域

  • 1篇农业科学
  • 1篇自然科学总论

主题

  • 1篇SEVERE
  • 1篇COMBIN...
  • 1篇RECONS...
  • 1篇INTERF...
  • 1篇SUPERI...
  • 1篇INTERF...

传媒

  • 1篇Chines...

年份

  • 1篇2011
1 条 记 录,以下是 1-1
排序方式:
Activity of superior interferon α against HIV-1 in severe combined immunodeficient mice reconstituted with human peripheral blood leukocytes
2011年
Background Interferon (IFN) can inhibit human immunodeficiency virus type 1 (HIV-1) replication in vitro and in clinic.However, IFN therapy for HIV infection was limited by its moderate antiviral efficacy and its frequent adverse effects. In the present study we evaluated the anti-HIV efficacy of a novel synthesized superior interferon α (slFNα).Methods We performed in vitro experiments with HIV-1 IIB infected MT4 cells, and evaluated in vivo anti-HIV efficacy of slFNα in severe combined immunodeficient (SClD) mice reconstituted with human peripheral blood leukocytes (hu-PBL-SClD mice).Results We found that the 50% effective concentrations (EC5o) of slFNα against the replication of HIV-1 in MT4 cells was 0.06 ng/ml, representing stronger antiviral activity than interferon-α in vitro. In the hu-PBL-SCID mice, a dose-dependent protection pattern was observed: with 0.45 μg and 1.35 μg slFNα daily treatments, parts of SCID mice were protected from HIV infection, whereas 2.25 μg sIFNα daily treatments resulted in a terminally complete protection.Conclusions slFNα shows good anti-HIV activity both in vitro and in SCID mice, may be a promising anti-HIV agent deserving clinical investigation, especially considering the potential of IFN-α to inhibit HIV replication in patients infected with drug-resistant variants or co-infected with hepatitis C virus (HCV).
ZHANG WeiTONG XiaoTadashi NakasoneYUE Xue-tianNaoki YamamotoLIU Xin-yuanYANG Rong-ge
关键词:INTERFERON-Α
共1页<1>
聚类工具0